Skip to main content

Abstract 16059: Real-World Exploration of Low Density Lipoprotein Cholesterol Management in Patients With Atherosclerotic Cardiovascular Disease

Publication ,  Conference
Shah, NP; Mulder, H; Lydon, B; Chiswell, K; Lampron, Z; Cohen, L; Hernandez, AF; Patel, MR; Taubes, S; Song, W; Mulukutla, SR; Saeed, A ...
Published in: Circulation
November 7, 2023

Although guidelines recommend low-density lipoprotein cholesterol (LDL-C) to bel <70mg/dL in patients with atherosclerotic cardiovascular disease (ASCVD), implementation of these recommendations remains low. To understand LDL-C management nationally and identify gaps or disparities in guideline directed care. A retrospective cohort study utilizing electronic medical record data from five health systems participating in the CardioHealth Alliance and PCORnet® was performed on patients with a LDL-C measurement in 2021 and prior ASCVD. Multivariable regression modeling was used to determine the relationship of clinical factors with guideline directed LDL-C targets. Among 216,074 ASCVD participants, only 86,188 (40%) had LDL-C <70 mg/dL. Compared with participants with uncontrolled LDL-C (≥70mg/dL), those with LDL-C <70 mg/dL tended to be male (64.9% vs 49.1%), White (87.3% vs 83.9%), had coronary artery disease (83.5% vs 73.0%), heart failure (29.1% vs 21.3%), diabetes (48.2% vs 34.1%), and atrial fibrillation (26.1% vs 19.3%). Among those with LDL-C ≥70 mg/dL not on lipid lowering therapy (LLT) at baseline (n=53,957 [41%]), only 20% were initiated on any LLT within 6 months of the elevated LDL-C value. Several factors were associated with not achieving LDL-C <70 mg/dL (Figure) including female sex (RR 1.13 [95% CI 1.12-1.14] p <0.001), Black race (1.15 [1.14-1.16] p <0.001), and Hispanic ethnicity (1.04 [1.01-1.06] p=0.007). Additionally, prior Lp(a) testing was associated with reaching LDL-C target (0.87 [0.82-0.92], p<0.001). Within five large U.S. health systems, only 40% of ASCVD patients achieved target LDL-C of <70 mg/dL. Patients who were female, Black, and/or Hispanic were particularly unlikely to achieve target, highlighting significant disparities. Multidisciplinary and inclusive approaches from health system to community may be needed to improve LDL-C care nationally.

Duke Scholars

Published In

Circulation

DOI

EISSN

1524-4539

ISSN

0009-7322

Publication Date

November 7, 2023

Volume

148

Issue

Suppl_1

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Shah, N. P., Mulder, H., Lydon, B., Chiswell, K., Lampron, Z., Cohen, L., … Pagidipati, N. J. (2023). Abstract 16059: Real-World Exploration of Low Density Lipoprotein Cholesterol Management in Patients With Atherosclerotic Cardiovascular Disease. In Circulation (Vol. 148). Ovid Technologies (Wolters Kluwer Health). https://doi.org/10.1161/circ.148.suppl_1.16059
Shah, Nishant P., Hillary Mulder, Betsy Lydon, Karen Chiswell, Zachary Lampron, Lauren Cohen, Adrian F. Hernandez, et al. “Abstract 16059: Real-World Exploration of Low Density Lipoprotein Cholesterol Management in Patients With Atherosclerotic Cardiovascular Disease.” In Circulation, Vol. 148. Ovid Technologies (Wolters Kluwer Health), 2023. https://doi.org/10.1161/circ.148.suppl_1.16059.
Shah NP, Mulder H, Lydon B, Chiswell K, Lampron Z, Cohen L, et al. Abstract 16059: Real-World Exploration of Low Density Lipoprotein Cholesterol Management in Patients With Atherosclerotic Cardiovascular Disease. In: Circulation. Ovid Technologies (Wolters Kluwer Health); 2023.
Shah, Nishant P., et al. “Abstract 16059: Real-World Exploration of Low Density Lipoprotein Cholesterol Management in Patients With Atherosclerotic Cardiovascular Disease.” Circulation, vol. 148, no. Suppl_1, Ovid Technologies (Wolters Kluwer Health), 2023. Crossref, doi:10.1161/circ.148.suppl_1.16059.
Shah NP, Mulder H, Lydon B, Chiswell K, Lampron Z, Cohen L, Hernandez AF, Patel MR, Taubes S, Song W, Mulukutla SR, Saeed A, Morin DP, Bradley SM, Hu X, Pagidipati NJ. Abstract 16059: Real-World Exploration of Low Density Lipoprotein Cholesterol Management in Patients With Atherosclerotic Cardiovascular Disease. Circulation. Ovid Technologies (Wolters Kluwer Health); 2023.

Published In

Circulation

DOI

EISSN

1524-4539

ISSN

0009-7322

Publication Date

November 7, 2023

Volume

148

Issue

Suppl_1

Publisher

Ovid Technologies (Wolters Kluwer Health)

Related Subject Headings

  • Cardiovascular System & Hematology
  • 4207 Sports science and exercise
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology